<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>References | Multi-State Clinical Prediction Models in Renal Replacement Therapy</title>
  <meta name="description" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  <meta name="generator" content="bookdown 0.17.2 and GitBook 2.6.7" />

  <meta property="og:title" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  
  
  

<meta name="author" content="Michael Andrew Barrowman" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="chap-dev-paper-supp.html"/>

<style type="text/css">
p.abstract{
  text-align: center;
  font-weight: bold;
}
div.abstract{
  margin: auto;
  width: 90%;
}
</style>
<script src="libs/header-attrs-2.1.1/header-attrs.js"></script>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />









<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/bsTable-3.3.7/bootstrapTable.min.css" rel="stylesheet" />
<script src="https://hypothes.is/embed.js" async></script>



</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Introduction</a>
<ul>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html#abstract"><i class="fa fa-check"></i>Abstract</a></li>
</ul></li>
<li class="chapter" data-level="1" data-path="chap-lit-report.html"><a href="chap-lit-report.html"><i class="fa fa-check"></i><b>1</b> Literature Report</a>
<ul>
<li class="chapter" data-level="1.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#introduction-1"><i class="fa fa-check"></i><b>1.1</b> Introduction</a></li>
<li class="chapter" data-level="1.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#clinical-prediction-models"><i class="fa fa-check"></i><b>1.2</b> Clinical Prediction Models</a>
<ul>
<li class="chapter" data-level="1.2.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#fundamental-prognosis-research"><i class="fa fa-check"></i><b>1.2.1</b> Fundamental Prognosis Research</a></li>
<li class="chapter" data-level="1.2.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#prognostic-factor-research"><i class="fa fa-check"></i><b>1.2.2</b> Prognostic Factor Research</a></li>
<li class="chapter" data-level="1.2.3" data-path="chap-lit-report.html"><a href="chap-lit-report.html#prognostic-model-research"><i class="fa fa-check"></i><b>1.2.3</b> Prognostic Model Research</a></li>
<li class="chapter" data-level="1.2.4" data-path="chap-lit-report.html"><a href="chap-lit-report.html#stratified-medicine"><i class="fa fa-check"></i><b>1.2.4</b> Stratified Medicine</a></li>
<li class="chapter" data-level="1.2.5" data-path="chap-lit-report.html"><a href="chap-lit-report.html#examples"><i class="fa fa-check"></i><b>1.2.5</b> Examples</a></li>
</ul></li>
<li class="chapter" data-level="1.3" data-path="chap-lit-report.html"><a href="chap-lit-report.html#competing-risks-multi-state-models"><i class="fa fa-check"></i><b>1.3</b> Competing Risks &amp; Multi-State Models</a></li>
<li class="chapter" data-level="1.4" data-path="chap-lit-report.html"><a href="chap-lit-report.html#chronic-kidney-disease"><i class="fa fa-check"></i><b>1.4</b> Chronic Kidney Disease</a>
<ul>
<li class="chapter" data-level="1.4.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#clinical-prediction-models-1"><i class="fa fa-check"></i><b>1.4.1</b> Clinical Prediction Models</a></li>
<li class="chapter" data-level="1.4.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#multi-state-models"><i class="fa fa-check"></i><b>1.4.2</b> Multi-State Models</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="2" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html"><i class="fa fa-check"></i><b>2</b> The Application of Multi-State Methods to Develop Clinical Prediction Models Designed for Clinical Use - A Scoping Review</a>
<ul>
<li class="chapter" data-level="2.1" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#introduction-2"><i class="fa fa-check"></i><b>2.1</b> Introduction</a></li>
<li class="chapter" data-level="2.2" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#methods"><i class="fa fa-check"></i><b>2.2</b> Methods</a>
<ul>
<li class="chapter" data-level="2.2.1" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#scope-of-review"><i class="fa fa-check"></i><b>2.2.1</b> Scope of Review</a></li>
<li class="chapter" data-level="2.2.2" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#initial-search-strategy"><i class="fa fa-check"></i><b>2.2.2</b> Initial Search Strategy</a></li>
<li class="chapter" data-level="2.2.3" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#filtering"><i class="fa fa-check"></i><b>2.2.3</b> Filtering</a></li>
<li class="chapter" data-level="2.2.4" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#data-extraction"><i class="fa fa-check"></i><b>2.2.4</b> Data Extraction</a></li>
<li class="chapter" data-level="2.2.5" data-path="chap-scoping-review.html"><a href="chap-scoping-review.html#reporting"><i class="fa fa-check"></i><b>2.2.5</b> Reporting</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html"><i class="fa fa-check"></i><b>3</b> How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies</a>
<ul>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#abstract-1"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#background"><i class="fa fa-check"></i>Background</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#methods-1"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#results"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#conclusion"><i class="fa fa-check"></i>Conclusion</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#supplementary-material"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="3.1" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#background-1"><i class="fa fa-check"></i><b>3.1</b> Background</a></li>
<li class="chapter" data-level="3.2" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#methods-2"><i class="fa fa-check"></i><b>3.2</b> Methods</a></li>
<li class="chapter" data-level="3.3" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#results-1"><i class="fa fa-check"></i><b>3.3</b> Results</a></li>
<li class="chapter" data-level="3.4" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#discussion"><i class="fa fa-check"></i><b>3.4</b> Discussion</a></li>
<li class="chapter" data-level="3.5" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#conclusion-1"><i class="fa fa-check"></i><b>3.5</b> Conclusion</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html"><i class="fa fa-check"></i><b>4</b> Inverse Probability Weighting Adjustment of the Logistic Regression Calibration-in-the-Large</a>
<ul>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#abstract-2"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#introduction-3"><i class="fa fa-check"></i>Introduction</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#methods-3"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#results-2"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#discussion-1"><i class="fa fa-check"></i>Discussion</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#supplementary-material-1"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="4.1" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#introduction-4"><i class="fa fa-check"></i><b>4.1</b> Introduction</a></li>
<li class="chapter" data-level="4.2" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#methods-4"><i class="fa fa-check"></i><b>4.2</b> Methods</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#theory"><i class="fa fa-check"></i><b>4.2.1</b> Theory</a></li>
<li class="chapter" data-level="4.2.2" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#aims"><i class="fa fa-check"></i><b>4.2.2</b> Aims</a></li>
<li class="chapter" data-level="4.2.3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#data-generating-method"><i class="fa fa-check"></i><b>4.2.3</b> Data Generating Method</a></li>
<li class="chapter" data-level="4.2.4" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#prediction-models"><i class="fa fa-check"></i><b>4.2.4</b> Prediction Models</a></li>
<li class="chapter" data-level="4.2.5" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#the-ipcw"><i class="fa fa-check"></i><b>4.2.5</b> The IPCW</a></li>
<li class="chapter" data-level="4.2.6" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#calibration-measurements"><i class="fa fa-check"></i><b>4.2.6</b> Calibration Measurements</a></li>
<li class="chapter" data-level="4.2.7" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#estimands"><i class="fa fa-check"></i><b>4.2.7</b> Estimands</a></li>
<li class="chapter" data-level="4.2.8" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#performance-measures"><i class="fa fa-check"></i><b>4.2.8</b> Performance Measures</a></li>
<li class="chapter" data-level="4.2.9" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#software"><i class="fa fa-check"></i><b>4.2.9</b> Software</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#results-3"><i class="fa fa-check"></i><b>4.3</b> Results</a></li>
<li class="chapter" data-level="4.4" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#discussion-2"><i class="fa fa-check"></i><b>4.4</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html"><i class="fa fa-check"></i><b>5</b> Prediction Model Performance Metrics for the Validation of Multi-State Clinical Prediction Models</a>
<ul>
<li class="chapter" data-level="5.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#introduction-5"><i class="fa fa-check"></i><b>5.1</b> Introduction</a></li>
<li class="chapter" data-level="5.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#motivating-data-set"><i class="fa fa-check"></i><b>5.2</b> Motivating Data Set</a></li>
<li class="chapter" data-level="5.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#current-approaches"><i class="fa fa-check"></i><b>5.3</b> Current Approaches</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#baseline-models"><i class="fa fa-check"></i><b>5.3.1</b> Baseline Models</a></li>
<li class="chapter" data-level="5.3.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#notation"><i class="fa fa-check"></i><b>5.3.2</b> Notation</a></li>
<li class="chapter" data-level="5.3.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#patient-weighting"><i class="fa fa-check"></i><b>5.3.3</b> Patient Weighting</a></li>
<li class="chapter" data-level="5.3.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy---brier-score"><i class="fa fa-check"></i><b>5.3.4</b> Accuracy - Brier Score</a></li>
<li class="chapter" data-level="5.3.5" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination---c-statistic"><i class="fa fa-check"></i><b>5.3.5</b> Discrimination - c-statistic</a></li>
<li class="chapter" data-level="5.3.6" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration---intercept-and-slope"><i class="fa fa-check"></i><b>5.3.6</b> Calibration - Intercept and Slope</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#extension-to-multi-state-models"><i class="fa fa-check"></i><b>5.4</b> Extension to Multi-State Models</a>
<ul>
<li class="chapter" data-level="5.4.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#trivial-extensions"><i class="fa fa-check"></i><b>5.4.1</b> Trivial Extensions</a></li>
<li class="chapter" data-level="5.4.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy---multiple-outcome-brier-score"><i class="fa fa-check"></i><b>5.4.2</b> Accuracy - Multiple Outcome Brier Score</a></li>
<li class="chapter" data-level="5.4.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination---polytomous-discriminatory-index"><i class="fa fa-check"></i><b>5.4.3</b> Discrimination - Polytomous Discriminatory Index</a></li>
<li class="chapter" data-level="5.4.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration---multinomial-intercept-matched-and-unmatched-slopes"><i class="fa fa-check"></i><b>5.4.4</b> Calibration - Multinomial Intercept, Matched and Unmatched Slopes</a></li>
</ul></li>
<li class="chapter" data-level="5.5" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#application-to-real-world-data"><i class="fa fa-check"></i><b>5.5</b> Application to Real-World Data</a>
<ul>
<li class="chapter" data-level="5.5.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy"><i class="fa fa-check"></i><b>5.5.1</b> Accuracy</a></li>
<li class="chapter" data-level="5.5.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination"><i class="fa fa-check"></i><b>5.5.2</b> Discrimination</a></li>
<li class="chapter" data-level="5.5.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration"><i class="fa fa-check"></i><b>5.5.3</b> Calibration</a></li>
</ul></li>
<li class="chapter" data-level="5.6" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discussion-3"><i class="fa fa-check"></i><b>5.6</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html"><i class="fa fa-check"></i><b>6</b> Development and External Validation of a Multi-State Clinical Prediction Model for Chronic Kidney Disease Patients Progressing onto Renal Replacement Therapy and Death</a>
<ul>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#abstract-3"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#introduction-6"><i class="fa fa-check"></i>Introduction</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#methods-5"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#results-4"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#discusssion"><i class="fa fa-check"></i>Discusssion</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#supplementary-material-2"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="6.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#introduction-7"><i class="fa fa-check"></i><b>6.1</b> Introduction</a></li>
<li class="chapter" data-level="6.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#methods-6"><i class="fa fa-check"></i><b>6.2</b> Methods</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#data-sources"><i class="fa fa-check"></i><b>6.2.1</b> Data Sources</a></li>
<li class="chapter" data-level="6.2.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#model-design"><i class="fa fa-check"></i><b>6.2.2</b> Model Design</a></li>
<li class="chapter" data-level="6.2.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#validation"><i class="fa fa-check"></i><b>6.2.3</b> Validation</a></li>
<li class="chapter" data-level="6.2.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#example"><i class="fa fa-check"></i><b>6.2.4</b> Example</a></li>
<li class="chapter" data-level="6.2.5" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#calculator"><i class="fa fa-check"></i><b>6.2.5</b> Calculator</a></li>
</ul></li>
<li class="chapter" data-level="6.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#results-5"><i class="fa fa-check"></i><b>6.3</b> Results</a>
<ul>
<li class="chapter" data-level="6.3.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#data-sources-separate-tables"><i class="fa fa-check"></i><b>6.3.1</b> Data Sources (Separate Tables)</a></li>
<li class="chapter" data-level="6.3.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#data-sources-single-table-draft"><i class="fa fa-check"></i><b>6.3.2</b> Data Sources (Single Table draft)</a></li>
<li class="chapter" data-level="6.3.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#development"><i class="fa fa-check"></i><b>6.3.3</b> Development</a></li>
<li class="chapter" data-level="6.3.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#validation-1"><i class="fa fa-check"></i><b>6.3.4</b> Validation</a></li>
<li class="chapter" data-level="6.3.5" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#example-1"><i class="fa fa-check"></i><b>6.3.5</b> Example</a></li>
<li class="chapter" data-level="6.3.6" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#calculator-1"><i class="fa fa-check"></i><b>6.3.6</b> Calculator</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#discussion-4"><i class="fa fa-check"></i><b>6.4</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="chap-conclusion.html"><a href="chap-conclusion.html"><i class="fa fa-check"></i><b>7</b> Conclusion</a></li>
<li class="appendix"><span><b>Appendices</b></span></li>
<li class="chapter" data-level="A" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html"><i class="fa fa-check"></i><b>A</b> How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies - Supplementary Material</a>
<ul>
<li class="chapter" data-level="A.1" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html#simulation-details"><i class="fa fa-check"></i><b>A.1</b> Simulation Details</a></li>
<li class="chapter" data-level="A.2" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html#mathematics-of-subdistribution-hazards"><i class="fa fa-check"></i><b>A.2</b> Mathematics of Subdistribution Hazards</a></li>
</ul></li>
<li class="chapter" data-level="B" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html"><i class="fa fa-check"></i><b>B</b> Inverse Probability Weighting Adjustment of the Logistic Regression Calibration-in-the-Large - Supplementary Material</a>
<ul>
<li class="chapter" data-level="B.1" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#calibration-slope"><i class="fa fa-check"></i><b>B.1</b> Calibration Slope</a>
<ul>
<li class="chapter" data-level="B.1.1" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#results-6"><i class="fa fa-check"></i><b>B.1.1</b> Results</a></li>
<li class="chapter" data-level="B.1.2" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#discussion-5"><i class="fa fa-check"></i><b>B.1.2</b> Discussion</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="C" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html"><i class="fa fa-check"></i><b>C</b> Development and External Validation of a Multi-State Clinical Prediction Model for Chronic Kidney Disease Patients Progressing onto Renal Replacement Therapy and Death - Supplementary Material</a>
<ul>
<li class="chapter" data-level="C.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#statistical-analysis"><i class="fa fa-check"></i><b>C.1</b> Statistical Analysis</a>
<ul>
<li class="chapter" data-level="C.1.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#development-1"><i class="fa fa-check"></i><b>C.1.1</b> Development</a></li>
<li class="chapter" data-level="C.1.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#validation-2"><i class="fa fa-check"></i><b>C.1.2</b> Validation</a></li>
</ul></li>
<li class="chapter" data-level="C.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#model-results"><i class="fa fa-check"></i><b>C.2</b> Model Results</a>
<ul>
<li class="chapter" data-level="C.2.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#two-state-model"><i class="fa fa-check"></i><b>C.2.1</b> Two State Model</a></li>
<li class="chapter" data-level="C.2.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#three-state-model"><i class="fa fa-check"></i><b>C.2.2</b> Three State Model</a></li>
<li class="chapter" data-level="C.2.3" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#five-state-model"><i class="fa fa-check"></i><b>C.2.3</b> Five State Model</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Multi-State Clinical Prediction Models in Renal Replacement Therapy</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="references" class="section level1 unnumbered" number="">
<h1>References</h1>
<!--
This manually sets the header for this unnumbered chapter.
-->
<!--
To remove the indentation of the first entry.
-->
<p></p>
<!--
To create a hanging indent and spacing between entries.  These three lines may need to be removed for styles that don't require the hanging indent.
-->
<!--
This is just for testing with more citations for the bibliography at the end.  Add other entries into the list here if you'd like them to appear in the bibliography even if they weren't explicitly cited in the document.
-->
<div id="refs" class="references">
<div>
<p>[1] Hippocrates and F. Adams, <em>The genuine works of Hippocrates;</em> New York, W. Wood and company, 1886.</p>
</div>
<div>
<p>[2] J. Hippisley-Cox, C. Coupland, and P. Brindle, “Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study,” <em>BMJ</em>, vol. 357, May 2017, doi: <a href="https://doi.org/10.1136/bmj.j2099">10.1136/bmj.j2099</a>.</p>
</div>
<div>
<p>[3] H. Hemingway <em>et al.</em>, “Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes,” <em>BMJ</em>, vol. 346, p. e5595, Feb. 2013, doi: <a href="https://doi.org/10.1136/bmj.e5595">10.1136/bmj.e5595</a>.</p>
</div>
<div>
<p>[4] K. Thygesen, J. S. Alpert, H. D. White, and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, “Universal definition of myocardial infarction,” <em>Journal of the American College of Cardiology</em>, vol. 50, no. 22, pp. 2173–2195, Nov. 2007, doi: <a href="https://doi.org/10.1016/j.jacc.2007.09.011">10.1016/j.jacc.2007.09.011</a>.</p>
</div>
<div>
<p>[5] Probst <em>et al.</em>, “Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome,” <em>Circulation</em>, vol. 121, no. 5, pp. 635–643, Feb. 2010, doi: <a href="https://doi.org/10.1161/CIRCULATIONAHA.109.887026">10.1161/CIRCULATIONAHA.109.887026</a>.</p>
</div>
<div>
<p>[6] R. D. Riley, D. van der Windt, P. Croft, and K. G. M. Moons, <em>Prognosis Research in Healthcare: Concepts, Methods, and Impact</em>, First. Oxford University Press, 2019.</p>
</div>
<div>
<p>[7] R. D. Riley <em>et al.</em>, “Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research,” <em>PLoS Medicine</em>, vol. 10, no. 2, Feb. 2013, doi: <a href="https://doi.org/10.1371/journal.pmed.1001380">10.1371/journal.pmed.1001380</a>.</p>
</div>
<div>
<p>[8] E. W. Steyerberg <em>et al.</em>, “Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research,” <em>PLOS Medicine</em>, vol. 10, no. 2, p. e1001381, Feb. 2013, doi: <a href="https://doi.org/10.1371/journal.pmed.1001381">10.1371/journal.pmed.1001381</a>.</p>
</div>
<div>
<p>[9] P. Royston, K. G. M. Moons, D. G. Altman, and Y. Vergouwe, “Prognosis and prognostic research: Developing a prognostic model,” <em>BMJ</em>, vol. 338, p. b604, Mar. 2009, doi: <a href="https://doi.org/10.1136/bmj.b604">10.1136/bmj.b604</a>.</p>
</div>
<div>
<p>[10] D. G. Altman, Y. Vergouwe, P. Royston, and K. G. M. Moons, “Prognosis and prognostic research: Validating a prognostic model,” <em>BMJ</em>, vol. 338, p. b605, May 2009, doi: <a href="https://doi.org/10.1136/bmj.b605">10.1136/bmj.b605</a>.</p>
</div>
<div>
<p>[11] K. G. M. Moons, P. Royston, Y. Vergouwe, D. E. Grobbee, and D. G. Altman, “Prognosis and prognostic research: What, why, and how?” <em>BMJ</em>, vol. 338, p. b375, Feb. 2009, doi: <a href="https://doi.org/10.1136/bmj.b375">10.1136/bmj.b375</a>.</p>
</div>
<div>
<p>[12] A. D. Hingorani <em>et al.</em>, “Prognosis research strategy (PROGRESS) 4: Stratified medicine research,” <em>BMJ</em>, vol. 346, p. e5793, Feb. 2013, doi: <a href="https://doi.org/10.1136/bmj.e5793">10.1136/bmj.e5793</a>.</p>
</div>
<div>
<p>[13] G. S. Collins, J. B. Reitsma, D. G. Altman, and K. G. Moons, “Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement,” <em>BMC Medicine</em>, vol. 13, no. 1, p. 1, Jan. 2015, doi: <a href="https://doi.org/10.1186/s12916-014-0241-z">10.1186/s12916-014-0241-z</a>.</p>
</div>
<div>
<p>[14] K. G. M. Moons <em>et al.</em>, “Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration,” <em>Annals of Internal Medicine</em>, vol. 162, no. 1, p. W1, Jan. 2015, doi: <a href="https://doi.org/10.7326/M14-0698">10.7326/M14-0698</a>.</p>
</div>
<div>
<p>[15] R. D. Riley <em>et al.</em>, “External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: Opportunities and challenges,” <em>BMJ</em>, vol. 353, Jun. 2016, doi: <a href="https://doi.org/10.1136/bmj.i3140">10.1136/bmj.i3140</a>.</p>
</div>
<div>
<p>[16] G. S. Collins, O. Omar, M. Shanyinde, and L.-M. Yu, “A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods,” <em>Journal of Clinical Epidemiology</em>, vol. 66, no. 3, pp. 268–277, Mar. 2013, doi: <a href="https://doi.org/10.1016/j.jclinepi.2012.06.020">10.1016/j.jclinepi.2012.06.020</a>.</p>
</div>
<div>
<p>[17] P. Royston, D. G. Altman, and W. Sauerbrei, “Dichotomizing continuous predictors in multiple regression: A bad idea,” <em>Statistics in Medicine</em>, vol. 25, no. 1, pp. 127–141, Jan. 2006, doi: <a href="https://doi.org/10.1002/sim.2331">10.1002/sim.2331</a>.</p>
</div>
<div>
<p>[18] S. E. Bleeker <em>et al.</em>, “External validation is necessary in prediction research: A clinical example,” <em>Journal of Clinical Epidemiology</em>, vol. 56, no. 9, pp. 826–832, Sep. 2003, doi: <a href="https://doi.org/10.1016/s0895-4356(03)00207-5">10.1016/s0895-4356(03)00207-5</a>.</p>
</div>
<div>
<p>[19] S. B. Hanauer, “Exploring the controversial themes of IBD,” <em>Inflammatory Bowel Diseases</em>, vol. 15, no. S1, pp. S1–S10, 2009, doi: <a href="https://doi.org/10.1002/ibd.20945">10.1002/ibd.20945</a>.</p>
</div>
<div>
<p>[20] J. Hippisley-Cox <em>et al.</em>, “Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2,” <em>BMJ</em>, vol. 336, no. 7659, pp. 1475–1482, Jun. 2008, doi: <a href="https://doi.org/10.1136/bmj.39609.449676.25">10.1136/bmj.39609.449676.25</a>.</p>
</div>
<div>
<p>[21] P. Peduzzi, J. Concato, E. Kemper, T. R. Holford, and A. R. Feinstein, “A simulation study of the number of events per variable in logistic regression analysis,” <em>Journal of Clinical Epidemiology</em>, vol. 49, no. 12, pp. 1373–1379, Dec. 1996, doi: <a href="https://doi.org/10.1016/S0895-4356(96)00236-3">10.1016/S0895-4356(96)00236-3</a>.</p>
</div>
<div>
<p>[22] R. D. Riley <em>et al.</em>, “Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes,” <em>Statistics in Medicine</em>, vol. 38, no. 7, pp. 1276–1296, 2019, doi: <a href="https://doi.org/10.1002/sim.7992">10.1002/sim.7992</a>.</p>
</div>
<div>
<p>[23] W. Sauerbrei, P. Royston, and H. Binder, “Selection of important variables and determination of functional form for continuous predictors in multivariable model building,” <em>Statistics in Medicine</em>, vol. 26, no. 30, pp. 5512–5528, 2007, doi: <a href="https://doi.org/10.1002/sim.3148">10.1002/sim.3148</a>.</p>
</div>
<div>
<p>[24] Y. Vergouwe, E. W. Steyerberg, M. J. C. Eijkemans, and J. D. F. Habbema, “Substantial effective sample sizes were required for external validation studies of predictive logistic regression models,” <em>Journal of Clinical Epidemiology</em>, vol. 58, no. 5, pp. 475–483, May 2005, doi: <a href="https://doi.org/10.1016/j.jclinepi.2004.06.017">10.1016/j.jclinepi.2004.06.017</a>.</p>
</div>
<div>
<p>[25] C. Counsell and M. Dennis, “Systematic review of prognostic models in patients with acute stroke,” <em>Cerebrovascular Diseases (Basel, Switzerland)</em>, vol. 12, no. 3, pp. 159–170, 2001, doi: <a href="https://doi.org/10.1159/000047699">10.1159/000047699</a>.</p>
</div>
<div>
<p>[26] J. Ivanov, M. A. Borger, T. E. David, G. Cohen, N. Walton, and C. D. Naylor, “Predictive accuracy study: Comparing a statistical model to clinicians’ estimates of outcomes after coronary bypass surgery,” <em>The Annals of Thoracic Surgery</em>, vol. 70, no. 1, pp. 162–168, Jul. 2000, doi: <a href="https://doi.org/10.1016/s0003-4975(00)01387-4">10.1016/s0003-4975(00)01387-4</a>.</p>
</div>
<div>
<p>[27] J. Hippisley-Cox, C. Coupland, Y. Vinogradova, J. Robson, M. May, and P. Brindle, “Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study,” <em>BMJ (Clinical research ed.)</em>, vol. 335, no. 7611, p. 136, Jul. 2007, doi: <a href="https://doi.org/10.1136/bmj.39261.471806.55">10.1136/bmj.39261.471806.55</a>.</p>
</div>
<div>
<p>[28] J. L. Haybittle <em>et al.</em>, “A prognostic index in primary breast cancer.” <em>British Journal of Cancer</em>, vol. 45, no. 3, pp. 361–366, Mar. 1982.</p>
</div>
<div>
<p>[29] J. H. Todd <em>et al.</em>, “Confirmation of a prognostic index in primary breast cancer,” <em>British Journal of Cancer</em>, vol. 56, no. 4, pp. 489–492, Oct. 1987, doi: <a href="https://doi.org/10.1038/bjc.1987.230">10.1038/bjc.1987.230</a>.</p>
</div>
<div>
<p>[30] A. Pate, R. Emsley, D. M. Ashcroft, B. Brown, and T. van Staa, “The uncertainty with using risk prediction models for individual decision making: An exemplar cohort study examining the prediction of cardiovascular disease in English primary care,” <em>BMC Medicine</em>, vol. 17, no. 1, p. 134, Jul. 2019, doi: <a href="https://doi.org/10.1186/s12916-019-1368-8">10.1186/s12916-019-1368-8</a>.</p>
</div>
<div>
<p>[31] P. Bhatnagar, K. Wickramasinghe, J. Williams, M. Rayner, and N. Townsend, “The epidemiology of cardiovascular disease in the UK 2014,” <em>Heart</em>, vol. 101, no. 15, pp. 1182–1189, Aug. 2015, doi: <a href="https://doi.org/10.1136/heartjnl-2015-307516">10.1136/heartjnl-2015-307516</a>.</p>
</div>
<div>
<p>[32] D. A. Jenkins, M. Sperrin, G. P. Martin, and N. Peek, “Dynamic models to predict health outcomes: Current status and methodological challenges,” <em>Diagnostic and Prognostic Research</em>, vol. 2, no. 1, p. 23, Dec. 2018, doi: <a href="https://doi.org/10.1186/s41512-018-0045-2">10.1186/s41512-018-0045-2</a>.</p>
</div>
<div>
<p>[33] B. Liquet, J.-F. Timsit, and V. Rondeau, “Investigating hospital heterogeneity with a multi-state frailty model: Application to nosocomial pneumonia disease in intensive care units,” <em>BMC medical research methodology</em>, vol. 12, p. 79, Jun. 2012, doi: <a href="https://doi.org/10.1186/1471-2288-12-79">10.1186/1471-2288-12-79</a>.</p>
</div>
<div>
<p>[34] K. I. E. Snell <em>et al.</em>, “Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model,” <em>Journal of Clinical Epidemiology</em>, vol. 69, pp. 40–50, Jan. 2016, doi: <a href="https://doi.org/10.1016/j.jclinepi.2015.05.009">10.1016/j.jclinepi.2015.05.009</a>.</p>
</div>
<div>
<p>[35] E. W. Steyerberg, <em>Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating</em>. Springer Science &amp; Business Media, 2008.</p>
</div>
<div>
<p>[36] B. V. Calster, D. Nieboer, Y. Vergouwe, B. D. Cock, M. J. Pencina, and E. W. Steyerberg, “A calibration hierarchy for risk models was defined: From utopia to empirical data,” <em>Journal of Clinical Epidemiology</em>, vol. 74, pp. 167–176, Jun. 2016, doi: <a href="https://doi.org/10.1016/j.jclinepi.2015.12.005">10.1016/j.jclinepi.2015.12.005</a>.</p>
</div>
<div>
<p>[37] P. Royston and D. G. Altman, “External validation of a Cox prognostic model: Principles and methods,” <em>BMC Medical Research Methodology</em>, vol. 13, no. 1, p. 33, Mar. 2013, doi: <a href="https://doi.org/10.1186/1471-2288-13-33">10.1186/1471-2288-13-33</a>.</p>
</div>
<div>
<p>[38] C. S. Crowson, E. J. Atkinson, and T. M. Therneau, “Assessing Calibration of Prognostic Risk Scores,” <em>Statistical methods in medical research</em>, vol. 25, no. 4, pp. 1692–1706, Aug. 2016, doi: <a href="https://doi.org/10.1177/0962280213497434">10.1177/0962280213497434</a>.</p>
</div>
<div>
<p>[39] H. C. van Houwelingen, “Validation, calibration, revision and combination of prognostic survival models,” <em>Statistics in Medicine</em>, vol. 19, no. 24, pp. 3401–3415, 2000, doi: <a href="https://doi.org/10.1002/1097-0258(20001230)19:24%3C3401::AID-SIM554%3E3.0.CO;2-2">10.1002/1097-0258(20001230)19:24&lt;3401::AID-SIM554&gt;3.0.CO;2-2</a>.</p>
</div>
<div>
<p>[40] P. Royston, “Tools for Checking Calibration of a Cox Model in External Validation: Approach Based on Individual Event Probabilities:” <em>The Stata Journal</em>, Dec. 2014, doi: <a href="https://doi.org/10.1177/1536867X1401400403">10.1177/1536867X1401400403</a>.</p>
</div>
<div>
<p>[41] M. P. Perme and P. K. Andersen, “Checking hazard regression models using pseudo-observations,” <em>Statistics in medicine</em>, vol. 27, no. 25, pp. 5309–5328, Nov. 2008, doi: <a href="https://doi.org/10.1002/sim.3401">10.1002/sim.3401</a>.</p>
</div>
<div>
<p>[42] P. Royston, “Tools for Checking Calibration of a Cox Model in External Validation: Prediction of Population-Averaged Survival Curves Based on Risk Groups,” <em>The Stata Journal</em>, vol. 15, no. 1, pp. 275–291, Apr. 2015, doi: <a href="https://doi.org/10.1177/1536867X1501500116">10.1177/1536867X1501500116</a>.</p>
</div>
<div>
<p>[43] T. A. Gerds and M. Schumacher, “Consistent Estimation of the Expected Brier Score in General Survival Models with Right-Censored Event Times,” <em>Biometrical Journal</em>, vol. 48, no. 6, pp. 1029–1040, 2006, doi: <a href="https://doi.org/10.1002/bimj.200610301">10.1002/bimj.200610301</a>.</p>
</div>
<div>
<p>[44] C. Spitoni, V. Lammens, and H. Putter, “Prediction errors for state occupation and transition probabilities in multi-state models,” <em>Biometrical Journal. Biometrische Zeitschrift</em>, vol. 60, no. 1, pp. 34–48, Jan. 2018, doi: <a href="https://doi.org/10.1002/bimj.201600191">10.1002/bimj.201600191</a>.</p>
</div>
<div>
<p>[45] X. Han, Y. Zhang, and Y. Shao, “On comparing two correlated C indices with censored survival data,” <em>Statistics in medicine</em>, vol. 36, no. 25, pp. 4041–4049, Nov. 2017, doi: <a href="https://doi.org/10.1002/sim.7414">10.1002/sim.7414</a>.</p>
</div>
<div>
<p>[46] X. Liu, Z. Jin, and J. H. Graziano, “Comparing paired biomarkers in predicting quantitative health outcome subject to random censoring,” <em>Statistical methods in medical research</em>, vol. 25, no. 1, pp. 447–457, Feb. 2016, doi: <a href="https://doi.org/10.1177/0962280212460434">10.1177/0962280212460434</a>.</p>
</div>
<div>
<p>[47] A. Burton, D. G. Altman, P. Royston, and R. L. Holder, “The design of simulation studies in medical statistics,” <em>Statistics in Medicine</em>, vol. 25, no. 24, pp. 4279–4292, Dec. 2006, doi: <a href="https://doi.org/10.1002/sim.2673">10.1002/sim.2673</a>.</p>
</div>
<div>
<p>[48] P. K. Andersen and M. Pohar Perme, “Pseudo-observations in survival analysis,” <em>Statistical Methods in Medical Research</em>, vol. 19, no. 1, pp. 71–99, Feb. 2010, doi: <a href="https://doi.org/10.1177/0962280209105020">10.1177/0962280209105020</a>.</p>
</div>
<div>
<p>[49] Wildscop, “Biostatistics and epidemiology with R: Weighted Logistic Regression in R, SPSS, Stata,” <em>biostatistics and epidemiology with R</em>. Feb-2013.</p>
</div>
<div>
<p>[50] T. P. Morris, I. R. White, and M. J. Crowther, “Using simulation studies to evaluate statistical methods,” <em>Statistics in Medicine</em>, vol. 38, no. 11, pp. 2074–2102, 2019, doi: <a href="https://doi.org/10.1002/sim.8086">10.1002/sim.8086</a>.</p>
</div>
<div>
<p>[51] R. C. Team, “R: A Language and Environment for Statistical Computing.” R Foundation for Statistical Computing, Vienna, Austria, Vienna,</p>
</div>
<div>
<p>[52] H. Wickham, “The tidy tools manifesto.” https://cran.r-project.org/web/packages/tidyverse/vignettes/manifesto.html, Nov-2017.</p>
</div>
<div>
<p>[53] T. Therneau, “A package for survival analysis in R,” p. 89, Mar. 2020.</p>
</div>
<div>
<p>[54] M. P. Perme, M. Gerster, and K. Rodrigues, “Pseudo: Computes Pseudo-Observations for Modeling.” Jul-2017.</p>
</div>
<div>
<p>[55] W. Chang <em>et al.</em>, “Shiny: Web Application Framework for R.” Mar-2020.</p>
</div>
<div>
<p>[56] E. S. Johnson, M. L. Thorp, X. Yang, O. L. Charansonney, and D. H. Smith, “Predicting renal replacement therapy and mortality in CKD,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 50, no. 4, pp. 559–565, Oct. 2007, doi: <a href="https://doi.org/10.1053/j.ajkd.2007.07.006">10.1053/j.ajkd.2007.07.006</a>.</p>
</div>
<div>
<p>[57] M. J. Landray <em>et al.</em>, “Prediction of ESRD and death among people with CKD: The Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 56, no. 6, pp. 1082–1094, Dec. 2010, doi: <a href="https://doi.org/10.1053/j.ajkd.2010.07.016">10.1053/j.ajkd.2010.07.016</a>.</p>
</div>
<div>
<p>[58] N. Bansal <em>et al.</em>, “Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 10, no. 3, pp. 363–371, Mar. 2015, doi: <a href="https://doi.org/10.2215/CJN.04650514">10.2215/CJN.04650514</a>.</p>
</div>
<div>
<p>[59] A. Marks <em>et al.</em>, “Looking to the future: Predicting renal replacement outcomes in a large community cohort with chronic kidney disease,” <em>Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association</em>, vol. 30, no. 9, pp. 1507–1517, Sep. 2015, doi: <a href="https://doi.org/10.1093/ndt/gfv089">10.1093/ndt/gfv089</a>.</p>
</div>
<div>
<p>[60] J. P. Wick <em>et al.</em>, “A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 69, no. 5, pp. 568–575, May 2017, doi: <a href="https://doi.org/10.1053/j.ajkd.2016.08.035">10.1053/j.ajkd.2016.08.035</a>.</p>
</div>
<div>
<p>[61] E. S. Johnson, M. L. Thorp, R. W. Platt, and D. H. Smith, “Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 52, no. 4, pp. 653–660, Oct. 2008, doi: <a href="https://doi.org/10.1053/j.ajkd.2008.04.026">10.1053/j.ajkd.2008.04.026</a>.</p>
</div>
<div>
<p>[62] E. B. Schroeder <em>et al.</em>, “Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 12, no. 1, pp. 87–94, Jun. 2017, doi: <a href="https://doi.org/10.2215/CJN.01290216">10.2215/CJN.01290216</a>.</p>
</div>
<div>
<p>[63] S. Kulkarni <em>et al.</em>, “Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling,” <em>PLOS ONE</em>, vol. 12, no. 12, p. e0190277, Dec. 2017, doi: <a href="https://doi.org/10.1371/journal.pone.0190277">10.1371/journal.pone.0190277</a>.</p>
</div>
<div>
<p>[64] J. Floege <em>et al.</em>, “Development and validation of a predictive mortality risk score from a European hemodialysis cohort,” <em>Kidney International</em>, vol. 87, no. 5, pp. 996–1008, May 2015, doi: <a href="https://doi.org/10.1038/ki.2014.419">10.1038/ki.2014.419</a>.</p>
</div>
<div>
<p>[65] A. C. Hemke, M. B. Heemskerk, M. van Diepen, W. Weimar, F. W. Dekker, and A. J. Hoitsma, “Survival prognosis after the start of a renal replacement therapy in the Netherlands: A retrospective cohort study,” <em>BMC Nephrology</em>, vol. 14, p. 258, Nov. 2013, doi: <a href="https://doi.org/10.1186/1471-2369-14-258">10.1186/1471-2369-14-258</a>.</p>
</div>
<div>
<p>[66] X.-Y. Cao <em>et al.</em>, “Predicting one-year mortality in peritoneal dialysis patients: An analysis of the China Peritoneal Dialysis Registry,” <em>International Journal of Medical Sciences</em>, vol. 12, no. 4, pp. 354–361, 2015, doi: <a href="https://doi.org/10.7150/ijms.11694">10.7150/ijms.11694</a>.</p>
</div>
<div>
<p>[67] N. Tangri <em>et al.</em>, “A predictive model for progression of chronic kidney disease to kidney failure,” <em>JAMA</em>, vol. 305, no. 15, pp. 1553–1559, Apr. 2011, doi: <a href="https://doi.org/10.1001/jama.2011.451">10.1001/jama.2011.451</a>.</p>
</div>
<div>
<p>[68] J. Roy <em>et al.</em>, “Statistical Methods for Cohort Studies of CKD: Prediction Modeling,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 12, no. 6, pp. 1010–1017, Jun. 2017, doi: <a href="https://doi.org/10.2215/CJN.06210616">10.2215/CJN.06210616</a>.</p>
</div>
<div>
<p>[69] N. Tangri <em>et al.</em>, “A Dynamic Predictive Model for Progression of CKD,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 69, no. 4, pp. 514–520, Apr. 2017, doi: <a href="https://doi.org/10.1053/j.ajkd.2016.07.030">10.1053/j.ajkd.2016.07.030</a>.</p>
</div>
<div>
<p>[70] M. G. Shlipak <em>et al.</em>, “Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors,” <em>JAMA</em>, vol. 293, no. 14, pp. 1737–1745, Apr. 2005, doi: <a href="https://doi.org/10.1001/jama.293.14.1737">10.1001/jama.293.14.1737</a>.</p>
</div>
<div>
<p>[71] D. E. Weiner <em>et al.</em>, “The Framingham predictive instrument in chronic kidney disease,” <em>Journal of the American College of Cardiology</em>, vol. 50, no. 3, pp. 217–224, Jul. 2007, doi: <a href="https://doi.org/10.1016/j.jacc.2007.03.037">10.1016/j.jacc.2007.03.037</a>.</p>
</div>
<div>
<p>[72] J. J. V. McMurray <em>et al.</em>, “Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT),” <em>American Heart Journal</em>, vol. 162, no. 4, pp. 748–755.e3, Oct. 2011, doi: <a href="https://doi.org/10.1016/j.ahj.2011.07.016">10.1016/j.ahj.2011.07.016</a>.</p>
</div>
<div>
<p>[73] M. E. Grams and J. Coresh, “Assessing risk in chronic kidney disease: A methodological review,” <em>Nature Reviews. Nephrology</em>, vol. 9, no. 1, pp. 18–25, Jan. 2013, doi: <a href="https://doi.org/10.1038/nrneph.2012.248">10.1038/nrneph.2012.248</a>.</p>
</div>
<div>
<p>[74] N. Tangri <em>et al.</em>, “Risk prediction models for patients with chronic kidney disease: A systematic review,” <em>Annals of Internal Medicine</em>, vol. 158, no. 8, pp. 596–603, Apr. 2013, doi: <a href="https://doi.org/10.7326/0003-4819-158-8-201304160-00004">10.7326/0003-4819-158-8-201304160-00004</a>.</p>
</div>
<div>
<p>[75] C. L. Ramspek, P. W. Voskamp, F. J. van Ittersum, R. T. Krediet, F. W. Dekker, and M. van Diepen, “Prediction models for the mortality risk in chronic dialysis patients: A systematic review and independent external validation study,” <em>Clinical Epidemiology</em>, vol. 9, pp. 451–464, 2017, doi: <a href="https://doi.org/10.2147/CLEP.S139748">10.2147/CLEP.S139748</a>.</p>
</div>
<div>
<p>[76] W. Bouwmeester <em>et al.</em>, “Reporting and Methods in Clinical Prediction Research: A Systematic Review,” <em>PLOS Medicine</em>, vol. 9, no. 5, p. e1001221, May 2012, doi: <a href="https://doi.org/10.1371/journal.pmed.1001221">10.1371/journal.pmed.1001221</a>.</p>
</div>
<div>
<p>[77] A. Perotte, R. Ranganath, J. S. Hirsch, D. Blei, and N. Elhadad, “Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis,” <em>Journal of the American Medical Informatics Association: JAMIA</em>, vol. 22, no. 4, pp. 872–880, Jul. 2015, doi: <a href="https://doi.org/10.1093/jamia/ocv024">10.1093/jamia/ocv024</a>.</p>
</div>
<div>
<p>[78] A. Begun, A. Icks, R. Waldeyer, S. Landwehr, M. Koch, and G. Giani, “Identification of a multistate continuous-time nonhomogeneous Markov chain model for patients with decreased renal function.” <em>Medical decision making : an international journal of the Society for Medical Decision Making</em>, vol. 33, no. 2, pp. 298–306, Feb. 2013, doi: <a href="https://doi.org/10.1177/0272989X12466731">10.1177/0272989X12466731</a>.</p>
</div>
<div>
<p>[79] A. M. Allen, W. R. Kim, T. M. Therneau, J. J. Larson, J. K. Heimbach, and A. D. Rule, “Chronic kidney disease and associated mortality after liver transplantation–a time-dependent analysis using measured glomerular filtration rate,” <em>Journal of Hepatology</em>, vol. 61, no. 2, pp. 286–292, Aug. 2014, doi: <a href="https://doi.org/10.1016/j.jhep.2014.03.034">10.1016/j.jhep.2014.03.034</a>.</p>
</div>
<div>
<p>[80] M. E. Grams <em>et al.</em>, “Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate,” <em>Kidney International</em>, vol. 93, no. 6, pp. 1442–1451, Jun. 2018, doi: <a href="https://doi.org/10.1016/j.kint.2018.01.009">10.1016/j.kint.2018.01.009</a>.</p>
</div>
<div>
<p>[81] D. G. Altman, “Problems in dichotomizing continuous variables,” <em>American Journal of Epidemiology</em>, vol. 139, no. 4, pp. 442–445, Feb. 1994, doi: <a href="https://doi.org/10.1093/oxfordjournals.aje.a117020">10.1093/oxfordjournals.aje.a117020</a>.</p>
</div>
<div>
<p>[82] D. G. Altman, B. Lausen, W. Sauerbrei, and M. Schumacher, “Dangers of Using ‘Optimal’ Cutpoints in the Evaluation of Prognostic Factors,” <em>JNCI: Journal of the National Cancer Institute</em>, vol. 86, no. 11, pp. 829–835, Jun. 1994, doi: <a href="https://doi.org/10.1093/jnci/86.11.829">10.1093/jnci/86.11.829</a>.</p>
</div>
<div>
<p>[83] D. G. Altman and P. Royston, “The cost of dichotomising continuous variables,” <em>BMJ</em>, vol. 332, no. 7549, p. 1080, May 2006, doi: <a href="https://doi.org/10.1136/bmj.332.7549.1080">10.1136/bmj.332.7549.1080</a>.</p>
</div>
<div>
<p>[84] C. Bennette and A. Vickers, “Against quantiles: Categorization of continuous variables in epidemiologic research, and its discontents,” <em>BMC Medical Research Methodology</em>, vol. 12, no. 1, p. 21, Feb. 2012, doi: <a href="https://doi.org/10.1186/1471-2288-12-21">10.1186/1471-2288-12-21</a>.</p>
</div>
<div>
<p>[85] M. M. Butts and T. W. H. Ng, “Chopped liver? OK. Chopped data? Not OK,” in <em>Statistical and methodological myths and urban legends: Doctrine, verity and fable in the organizational and social sciences</em>, New York, NY, US: Routledge/Taylor &amp; Francis Group, 2009, pp. 361–386.</p>
</div>
<div>
<p>[86] P. M. Cumberland <em>et al.</em>, “Ophthalmic statistics note: The perils of dichotomising continuous variables,” <em>British Journal of Ophthalmology</em>, vol. 98, no. 6, pp. 841–843, Jun. 2014, doi: <a href="https://doi.org/10.1136/bjophthalmol-2014-304930">10.1136/bjophthalmol-2014-304930</a>.</p>
</div>
<div>
<p>[87] N. V. Dawson and R. Weiss, “Dichotomizing continuous variables in statistical analysis: A practice to avoid,” <em>Medical Decision Making: An International Journal of the Society for Medical Decision Making</em>, vol. 32, no. 2, pp. 225–226, doi: <a href="https://doi.org/10.1177/0272989X12437605">10.1177/0272989X12437605</a>.</p>
</div>
<div>
<p>[88] T. E. Dinero, “Seven reasons why you should not categorize continuous data,” <em>Journal of Health &amp; Social Policy</em>, vol. 8, no. 1, pp. 63–72, 1996, doi: <a href="https://doi.org/10.1300/J045v08n01_06">10.1300/J045v08n01_06</a>.</p>
</div>
<div>
<p>[89] J. R. Irwin and G. H. McClelland, “Negative Consequences of Dichotomizing Continuous Predictor Variables,” <em>Journal of Marketing Research</em>, vol. 40, no. 3, pp. 366–371, Aug. 2003, doi: <a href="https://doi.org/10.1509/jmkr.40.3.366.19237">10.1509/jmkr.40.3.366.19237</a>.</p>
</div>
<div>
<p>[90] O. Kuss, “The danger of dichotomizing continuous variables: A visualization,” <em>Teaching Statistics</em>, vol. 35, no. 2, pp. 78–79, 2013, doi: <a href="https://doi.org/10.1111/test.12006">10.1111/test.12006</a>.</p>
</div>
<div>
<p>[91] K. Metze, “Dichotomization of continuous data–a pitfall in prognostic factor studies,” <em>Pathology, Research and Practice</em>, vol. 204, no. 3, pp. 213–214, 2008, doi: <a href="https://doi.org/10.1016/j.prp.2007.12.002">10.1016/j.prp.2007.12.002</a>.</p>
</div>
<div>
<p>[92] O. Naggara, J. Raymond, F. Guilbert, D. Roy, A. Weill, and D. G. Altman, “Analysis by categorizing or dichotomizing continuous variables is inadvisable: An example from the natural history of unruptured aneurysms,” <em>AJNR. American journal of neuroradiology</em>, vol. 32, no. 3, pp. 437–440, Mar. 2011, doi: <a href="https://doi.org/10.3174/ajnr.A2425">10.3174/ajnr.A2425</a>.</p>
</div>
<div>
<p>[93] S. V. Owen and R. D. Froman, “Why carve up your continuous data?” <em>Research in Nursing &amp; Health</em>, vol. 28, no. 6, pp. 496–503, 2005, doi: <a href="https://doi.org/10.1002/nur.20107">10.1002/nur.20107</a>.</p>
</div>
<div>
<p>[94] J. M. Schellingerhout, M. W. Heymans, H. C. W. de Vet, B. W. Koes, and A. P. Verhagen, “Categorizing continuous variables resulted in different predictors in a prognostic model for nonspecific neck pain,” <em>Journal of Clinical Epidemiology</em>, vol. 62, no. 8, pp. 868–874, Aug. 2009, doi: <a href="https://doi.org/10.1016/j.jclinepi.2008.10.010">10.1016/j.jclinepi.2008.10.010</a>.</p>
</div>
<div>
<p>[95] D. L. Streiner, “Breaking up is hard to do: The heartbreak of dichotomizing continuous data,” <em>Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie</em>, vol. 47, no. 3, pp. 262–266, Apr. 2002, doi: <a href="https://doi.org/10.1177/070674370204700307">10.1177/070674370204700307</a>.</p>
</div>
<div>
<p>[96] C. van Walraven and R. G. Hart, “Leave ’em alone - why continuous variables should be analyzed as such,” <em>Neuroepidemiology</em>, vol. 30, no. 3, pp. 138–139, 2008, doi: <a href="https://doi.org/10.1159/000126908">10.1159/000126908</a>.</p>
</div>
<div>
<p>[97] A. M. Vintzileos, Y. Oyelese, and C. V. Ananth, “The "anathema" of arbitrary categorization of continuous predictors,” <em>American Journal of Obstetrics and Gynecology</em>, vol. 210, no. 3, pp. 200–203, Mar. 2014, doi: <a href="https://doi.org/10.1016/j.ajog.2013.09.042">10.1016/j.ajog.2013.09.042</a>.</p>
</div>
<div>
<p>[98] C. R. Weinberg, “How Bad Is Categorization?” <em>Epidemiology</em>, vol. 6, no. 4, pp. 345–347, 1995.</p>
</div>
<div>
<p>[99] M. van Smeden, T. L. Lash, and R. H. H. Groenwold, “Reflection on modern methods: Five myths about measurement error in epidemiological research,” <em>International Journal of Epidemiology</em>, Oct. 19AD, doi: <a href="https://doi.org/10.1093/ije/dyz251">10.1093/ije/dyz251</a>.</p>
</div>
<div>
<p>[100] J. Sun, “Interval Censoring,” in <em>Encyclopedia of Biostatistics</em>, American Cancer Society, 2005.</p>
</div>
<div>
<p>[101] R. A. Hoefield <em>et al.</em>, “Factors associated with kidney disease progression and mortality in a referred CKD population,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 56, no. 6, pp. 1072–1081, Dec. 2010, doi: <a href="https://doi.org/10.1053/j.ajkd.2010.06.010">10.1053/j.ajkd.2010.06.010</a>.</p>
</div>
<div>
<p>[102] R. Chinnadurai, C. Chrysochou, and P. A. Kalra, “Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease,” <em>Nephron</em>, vol. 141, no. 1, pp. 24–30, 2019, doi: <a href="https://doi.org/10.1159/000493472">10.1159/000493472</a>.</p>
</div>
<div>
<p>[103] A. S. Levey <em>et al.</em>, “A new equation to estimate glomerular filtration rate,” <em>Annals of Internal Medicine</em>, vol. 150, no. 9, pp. 604–612, May 2009, doi: <a href="https://doi.org/10.7326/0003-4819-150-9-200905050-00006">10.7326/0003-4819-150-9-200905050-00006</a>.</p>
</div>
<div>
<p>[104] J. P. New, N. D. Bakerly, D. Leather, and A. Woodcock, “Obtaining real-world evidence: The Salford Lung Study,” <em>Thorax</em>, vol. 69, pp. 1152–1154, 2014, doi: <a href="https://doi.org/http://dx.doi.org/10.1136/thoraxjnl-2014-205259">http://dx.doi.org/10.1136/thoraxjnl-2014-205259</a>.</p>
</div>
<div>
<p>[105] K. Matsushita <em>et al.</em>, “Cohort Profile: The Chronic Kidney Disease Prognosis Consortium,” <em>International Journal of Epidemiology</em>, vol. 42, no. 6, pp. 1660–1668, Dec. 2013, doi: <a href="https://doi.org/10.1093/ije/dys173">10.1093/ije/dys173</a>.</p>
</div>
<div>
<p>[106] L. G. Forni <em>et al.</em>, “Renal recovery after acute kidney injury,” <em>Intensive Care Medicine</em>, vol. 43, no. 6, pp. 855–866, 2017, doi: <a href="https://doi.org/10.1007/s00134-017-4809-x">10.1007/s00134-017-4809-x</a>.</p>
</div>
<div>
<p>[107] “KDIGO Clinical Practice Guideline for Acute Kidney Injury,” <em>OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF NEPHROLOGY</em>, p. 141, 2012.</p>
</div>
<div>
<p>[108] I. R. White and P. Royston, “Imputing missing covariate values for the Cox model,” <em>Statistics in Medicine</em>, vol. 28, no. 15, pp. 1982–1998, Jul. 2009, doi: <a href="https://doi.org/10.1002/sim.3618">10.1002/sim.3618</a>.</p>
</div>
<div>
<p>[109] G. Venkat-Raman <em>et al.</em>, “New primary renal diagnosis codes for the ERA-EDTA,” <em>Nephrology Dialysis Transplantation</em>, vol. 27, no. 12, pp. 4414–4419, Dec. 2012, doi: <a href="https://doi.org/10.1093/ndt/gfs461">10.1093/ndt/gfs461</a>.</p>
</div>
<div>
<p>[110] C. P. Kovesdy <em>et al.</em>, “Past Decline Versus Current eGFR and Subsequent ESRD Risk,” <em>Journal of the American Society of Nephrology</em>, vol. 27, no. 8, pp. 2447–2455, Aug. 2016, doi: <a href="https://doi.org/10.1681/ASN.2015060687">10.1681/ASN.2015060687</a>.</p>
</div>
<div>
<p>[111] D. M. J. Naimark <em>et al.</em>, “Past Decline Versus Current eGFR and Subsequent Mortality Risk,” <em>Journal of the American Society of Nephrology</em>, vol. 27, no. 8, pp. 2456–2466, Aug. 2016, doi: <a href="https://doi.org/10.1681/ASN.2015060688">10.1681/ASN.2015060688</a>.</p>
</div>
<div>
<p>[112] M. Schomaker and C. Heumann, “Bootstrap inference when using multiple imputation,” <em>Statistics in Medicine</em>, vol. 37, no. 14, pp. 2252–2266, 2018, doi: <a href="https://doi.org/10.1002/sim.7654">10.1002/sim.7654</a>.</p>
</div>
<div>
<p>[113] S. van Buuren and K. Groothuis-Oudshoorn, “Mice: Multivariate Imputation by Chained Equations in R,” <em>Journal of Statistical Software</em>, vol. 45, no. 1, pp. 1–67, Dec. 2011, doi: <a href="https://doi.org/10.18637/jss.v045.i03">10.18637/jss.v045.i03</a>.</p>
</div>
<div>
<p>[114] C. Jackson, “Flexsurv: A Platform for Parametric Survival Modelling in R,” p. 33.</p>
</div>
<div>
<p>[115] B. Ripley and W. Venables, “Package ’nnet’,” Feb-2016.</p>
</div>
<div>
<p>[116] D. Vaughan and M. Dancho, “Furrr: Apply Mapping Functions in Parallel using Futures.” May-2018.</p>
</div>
<div>
<p>[117] P. Royston and M. K. B. Parmar, “Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects,” <em>Statistics in Medicine</em>, vol. 21, no. 15, pp. 2175–2197, Aug. 2002, doi: <a href="https://doi.org/10.1002/sim.1203">10.1002/sim.1203</a>.</p>
</div>
<div>
<p>[118] K. G. M. Moons, D. G. Altman, Y. Vergouwe, and P. Royston, “Prognosis and prognostic research: Application and impact of prognostic models in clinical practice,” <em>BMJ</em>, vol. 338, p. b606, Jun. 2009, doi: <a href="https://doi.org/10.1136/bmj.b606">10.1136/bmj.b606</a>.</p>
</div>
<div>
<p>[119] L. Meira-Machado, J. de Una-Alvarez, C. Cadarso-Suarez, and P. K. Andersen, “Multi-state models for the analysis of time-to-event data,” <em>Statistical methods in medical research</em>, vol. 18, no. 2, pp. 195–222, Apr. 2009, doi: <a href="https://doi.org/10.1177/0962280208092301">10.1177/0962280208092301</a>.</p>
</div>
<div>
<p>[120] H. Putter, M. Fiocco, and R. B. Geskus, “Tutorial in biostatistics: Competing risks and multi-state models,” <em>Statistics in Medicine</em>, vol. 26, no. 11, pp. 2389–2430, May 2007, doi: <a href="https://doi.org/10.1002/sim.2712">10.1002/sim.2712</a>.</p>
</div>
<div>
<p>[121] A. M. Wood, I. R. White, and P. Royston, “How should variable selection be performed with multiply imputed data?” <em>Statistics in Medicine</em>, vol. 27, no. 17, pp. 3227–3246, Jul. 2008, doi: <a href="https://doi.org/10.1002/sim.3177">10.1002/sim.3177</a>.</p>
</div>
<div>
<p>[122] D. B. Rubin, <em>Multiple Imputation for Nonresponse in Surveys</em>. New York, NY: John Wiley &amp; Sons, Inc, 1984.</p>
</div>
<div>
<p>[123] K. J. M. Janssen <em>et al.</em>, “Dealing with missing predictor values when applying clinical prediction models,” <em>Clinical Chemistry</em>, vol. 55, no. 5, pp. 994–1001, May 2009, doi: <a href="https://doi.org/10.1373/clinchem.2008.115345">10.1373/clinchem.2008.115345</a>.</p>
</div>
<div>
<p>[124] T. Gneiting and A. E. Raftery, “Strictly Proper Scoring Rules, Prediction, and Estimation,” <em>Journal of the American Statistical Association</em>, vol. 102, no. 477, pp. 359–378, Mar. 2007, doi: <a href="https://doi.org/10.1198/016214506000001437">10.1198/016214506000001437</a>.</p>
</div>
<div>
<p>[125] B. V. Calster, V. V. Belle, Y. Vergouwe, D. Timmerman, S. V. Huffel, and E. W. Steyerberg, “Extending the c-statistic to nominal polytomous outcomes: The Polytomous Discrimination Index,” <em>Statistics in Medicine</em>, vol. 31, no. 23, pp. 2610–2626, 2012, doi: <a href="https://doi.org/10.1002/sim.5321">10.1002/sim.5321</a>.</p>
</div>
<div>
<p>[126] K. V. Hoorde, Y. Vergouwe, D. Timmerman, S. V. Huffel, E. W. Steyerberg, and B. V. Calster, “Assessing calibration of multinomial risk prediction models,” <em>Statistics in Medicine</em>, vol. 33, no. 15, pp. 2585–2596, Jul. 2014, doi: <a href="https://doi.org/10.1002/sim.6114">10.1002/sim.6114</a>.</p>
</div>
</div>

</div>
            </section>

          </div>
        </div>
      </div>
<a href="chap-dev-paper-supp.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": [["thesis.pdf", "PDF"]],
"toc": {
"collapse": "section"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
